Health Care

Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon.

Biotech drugmaker Amgen said Tuesday it filed for marketing approval of a drug designed to treat a symptom of chronic kidney disease.

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of injectable drug and infusion device maker Hospira, and says the deal will close in early September.

Three New York hospitals and a health care management company have agreed to an $8 million settlement with state and federal authorities to resolve allegations they illegally billed Medicaid, the state's attorney general announced Monday.

Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Valeant Pharmaceuticals International Inc., down $15.85 to $229.06 The drug developer will pay about $1 billion to buy Sprout Pharmaceuticals, which makes the first women's libido drug, Addyi.

A Pasadena hospital says some patients have been infected with an antibiotic-resistant "superbug" that's been linked to a widely used medical scope.

The U.S. Department of Agriculture is taking bids from animal health companies for a bird flu vaccine.

Biotech drugmaker Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC.

Federal regulators have uncovered new violations by the manufacturer of medical scopes recently linked to outbreaks of deadly "superbug" bacteria at U.S. hospitals.

A chemical leak sent at least 15 people to a hospital for treatment before it was stopped at a plant on Terre Haute's south side, authorities said.

CVS Health Corporation (CVS) on Tuesday reported second-quarter earnings of $1.27 billion.

Mylan lowered the bar for shareholder approval in its ongoing hostile bid for rival pharmaceutical company Perrigo.

Global Blood Therapeutics shares surged Wednesday after the blood disorder drug developer's initial public offering raised $120 million, more than it had expected.

Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable people — babies and senior citizens.

Amarin Corporation has won an early victory in federal court against the Food and Drug Administration over the right to promote unapproved uses of its prescription fish-oil pill.

Allergan PLC (AGN) on Thursday reported a second-quarter loss of $243.1 million, after reporting a profit in the same period a year earlier.

IBM says it will pay $1 billion to acquire medical imaging and software company Merge Healthcare, part of an effort to boost the health care capabilities of Watson, its cognitive computing system.